India: Patent

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
USPTO Streamlined Claim Set Pilot Program: A Strategic Pathway To Accelerated Patent Examination
Patent pendency remains one of the most significant challenges in U.S. patent prosecution. Average first-action wait times range from approximately 20 to 29 months across Technology Centers, creating real costs for startups seeking investor credibility, life sciences companies racing toward product launches, and technology firms defending competitive market position.
India IP
SR
S.S. Rana & Co. Advocates
Article
Intellectual Property Rights Newsletter August 2026
In ANI Media Pvt. Ltd. v. Open AI OpCo LLC, CS(COMM) 1028/2024, the Delhi High Court delivered a significant judgment on the intersection of copyright law and Generative Artificial Intelligence. Deciding an application for interim injunction, the Court examined questions concerning the use of copyrighted works for training Large Language Models (LLMs), the scope of copyright infringement arising from AI-generated outputs, the applicability of the fair dealing exception under Section 52 of the Copyright Act, 1957, and the territorial jurisdiction of Indian courts over AI developers operating through servers located overseas.
India IP
KS
King, Stubb & Kasiva
Article
AI-Assisted Inventions In India: What Businesses Need To Know About Patentability And Disclosure
Artificial intelligence is changing not only how products are developed, but also how inventions are conceived, tested and refined. AI and machine learning systems are increasingly being used to identify new materials, optimise industrial processes, improve medical technologies, detect anomalies, develop software architectures and generate technical solutions that may ultimately form part of a patentable invention.
India IP
KS
King, Stubb & Kasiva
Article
Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector
India's healthcare, pharmaceutical, and medical devices sectors have witnessed significant regulatory, policy, and judicial developments aimed at strengthening oversight, enhancing patient safety, and promoting export competitiveness. From revised pharmacovigilance requirements to comprehensive pharmacy education reforms and landmark judicial rulings on drug pricing and patent law, these changes are reshaping the regulatory landscape for healthcare stakeholders.
India Healthcare
I
CMS INDUSLAW
Article
Intellectual Property Newsletter | June 2026
The June 2026 edition of Dentons Link Legal IP & Technology Newsletter examines the global intellectual property ecosystem's strong momentum, featuring record-high filings, AI-driven innovation surges, and pivotal rulings that reflect technological advancement and evolving regulatory priorities. From bizarre patent cases like motorized pasta forks to multimillion-dollar verdicts collapsed by procedural flaws, the newsletter explores landmark decisions in pharmaceutical patents, trademark enforcement, and AI
India IP
DL
Dentons Link Legal
Article
Intellectual Property Rights - July 2026
In Astral Ltd. v. M/s Astral Marketing Syndicate & Anr., CS (COMM) 294/2024, the Delhi High Court dismissed an application seeking rejection of the plaint for lack of territorial jurisdiction. The Court held that, at the stage of considering an objection under Order VII Rule 11 of the Code of Civil Procedure, the averments in the plaint must be accepted as true. It further observed that an interactive listing on a third-party platform such as Justdial, through which consumers can access product catalogues, initiate enquiries, and contact the Defendant, is sufficient to prima facie confer territorial jurisdiction in an internet-based trademark dispute.
India IP
KS
King, Stubb & Kasiva
Article
When The File Moved On, The Order Stood Still: The Delhi High Court Remands Medilabo On Section 3(i)
The Delhi High Court in Medilabo RFP Inc. v. Controller of Patents[1] set aside a refusal under Section 3(i) of the Patents Act, 1970 concerning a pharmaceutical invention for neurodegenerative diseases, The Court’s intervention turned on a more fundamental principle of patent adjudication: the Controller must decide an application on the basis of the claims as they stand on the date of the order and must deal with every objection raised in the hearing notice through reasoned findings.
India IP
SR
S.S. Rana & Co. Advocates
Article
India And USTR Priority Watch List: 15 Years Of Friction And Whether The EU FTA Changes The Equation
India has remained on the US Trade Representative's Priority Watch List for over 15 years due to ongoing disputes over intellectual property protection, particularly concerning pharmaceutical patents, compulsory licensing, and data exclusivity. With the recent India-EU Free Trade Agreement signed in January 2026, questions arise about whether this landmark deal will alter the dynamics of US-India trade negotiations and India's controversial IP stance.
India International
MC
MAHESHWARI & CO. Advocates & Legal Consultants
See more